These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27997812)

  • 21. Biosimilar peptides: need for pharmacovigilance.
    Joshi SR
    J Assoc Physicians India; 2011 Apr; 59 Suppl():44-7. PubMed ID: 21818998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The end of the beginning?
    Nat Biotechnol; 2006 Apr; 24(4):367. PubMed ID: 16601702
    [No Abstract]   [Full Text] [Related]  

  • 23. Multinational medicines--ensuring drug quality in an era of global manufacturing.
    Okie S
    N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulatory status of medicinal products for human beings in the European Union. The role of generic products.
    Minghetti P
    Pharmacol Res; 1996; 34(1-2):3-7. PubMed ID: 8981548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A divided INN crowd.
    Chin WW
    Nat Biotechnol; 2014 Feb; 32(2):130. PubMed ID: 24509752
    [No Abstract]   [Full Text] [Related]  

  • 26. A divided INN crowd.
    Greenwood J
    Nat Biotechnol; 2014 Feb; 32(2):131-2. PubMed ID: 24509753
    [No Abstract]   [Full Text] [Related]  

  • 27. A divided INN crowd.
    Eich G
    Nat Biotechnol; 2014 Feb; 32(2):131. PubMed ID: 24509754
    [No Abstract]   [Full Text] [Related]  

  • 28. A divided INN crowd.
    Schellekens H
    Nat Biotechnol; 2014 Feb; 32(2):132. PubMed ID: 24509755
    [No Abstract]   [Full Text] [Related]  

  • 29. An uncertain future for cardiovascular drug development?
    Garber AM
    N Engl J Med; 2009 Mar; 360(12):1169-71. PubMed ID: 19297568
    [No Abstract]   [Full Text] [Related]  

  • 30. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 31. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
    Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV
    AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory Science Approach in Pharmaceutical Development of Follow-on Versions of Non-Biological Complex Drug Products.
    Zagalo DM; Simões S; Sousa J
    J Pharm Sci; 2022 Oct; 111(10):2687-2713. PubMed ID: 35901943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Generics and brands in chemotherapy].
    Grigor'ev VIu
    Antibiot Khimioter; 2006; 51(8):38-47. PubMed ID: 18030783
    [No Abstract]   [Full Text] [Related]  

  • 34. An audience with... Thomas Lönngren.
    Lönngren T
    Nat Rev Drug Discov; 2006 Mar; 5(3):182. PubMed ID: 16557656
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA reiterates warning against online drug buying.
    Rados C
    FDA Consum; 2004; 38(5):17. PubMed ID: 15595143
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence Decision.
    Gaspar RS; Silva-Lima B; Magro F; Alcobia A; da Costa FL; Feio J
    Front Med (Lausanne); 2020; 7():590527. PubMed ID: 33330550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to select a nanosimilar.
    Astier A; Barton Pai A; Bissig M; Crommelin DJA; Flühmann B; Hecq JD; Knoeff J; Lipp HP; Morell-Baladrón A; Mühlebach S
    Ann N Y Acad Sci; 2017 Nov; 1407(1):50-62. PubMed ID: 28715605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC
    J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biosimilar products comparable to original preparations. The Medical Products Agency will not yet classify the agents as generics].
    Welin M; Liliemark J
    Lakartidningen; 2009 Jun 3-9; 106(23):1547-8. PubMed ID: 19583011
    [No Abstract]   [Full Text] [Related]  

  • 40. Registration of similar biological products--Singapore's approach.
    Poh J; Tam KT
    Biologicals; 2011 Sep; 39(5):343-5. PubMed ID: 21783381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.